Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
$0.35
$0.35
$0.17
$0.40
$94.74M1.372.03 million shsN/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$1.53
+9.7%
$1.80
$0.90
$4.98
$383.90M2.453.85 million shs4.32 million shs
RxSight, Inc. stock logo
RXST
RxSight
$9.28
+6.3%
$9.82
$6.32
$58.23
$379.74M1.161.04 million shs1.35 million shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$45.00
+9.1%
$35.42
$5.21
$46.58
$385.65M1.2952,178 shs75,243 shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
0.00%0.00%0.00%0.00%+4.32%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-1.41%-0.71%-26.39%-36.01%+49.36%
RxSight, Inc. stock logo
RXST
RxSight
+3.31%+6.20%+20.25%-44.32%-83.73%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
+4.59%+9.21%+16.72%+44.52%+4,125,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
N/AN/AN/AN/AN/AN/AN/AN/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
3.1548 of 5 stars
3.43.00.00.03.22.50.6
RxSight, Inc. stock logo
RXST
RxSight
0.9046 of 5 stars
2.01.00.00.01.71.70.6
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.9675 of 5 stars
2.50.00.00.00.62.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
0.00
N/AN/AN/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.75
Moderate Buy$3.0096.72% Upside
RxSight, Inc. stock logo
RXST
RxSight
1.91
Reduce$10.007.76% Upside
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
3.00
Buy$55.0022.22% Upside

Current Analyst Ratings Breakdown

Latest ASXC, BFLY, SNWV, and RXST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/22/2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$54.00 ➝ $55.00
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $8.00
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$9.00 ➝ $8.00
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$22.00 ➝ $11.00
8/4/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingPositive ➝ Positive$2.00
8/1/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform
7/29/2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$49.00
7/15/2025
RxSight, Inc. stock logo
RXST
RxSight
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$20.00 ➝ $9.00
7/10/2025
RxSight, Inc. stock logo
RXST
RxSight
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$24.00 ➝ $9.00
7/9/2025
RxSight, Inc. stock logo
RXST
RxSight
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderperform ➝ Underperform$18.00 ➝ $9.00
7/9/2025
RxSight, Inc. stock logo
RXST
RxSight
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $10.00
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
$8.58M11.04N/AN/A$0.13 per share2.68
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$82.06M4.68N/AN/A$0.92 per share1.66
RxSight, Inc. stock logo
RXST
RxSight
$139.93M2.71N/AN/A$6.79 per share1.37
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$32.63M11.82N/AN/A($1.72) per share-26.16
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
-$78.43M-$0.31N/AN/AN/A-902.25%-184.10%-114.75%N/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$72.49M-$0.28N/AN/AN/A-71.79%-30.53%-21.80%11/7/2025 (Estimated)
RxSight, Inc. stock logo
RXST
RxSight
-$27.45M-$0.80N/AN/AN/A-21.93%-11.56%-10.31%11/6/2025 (Estimated)
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$31.37M-$8.25N/AN/A-97.03%N/A-135.15%N/A

Latest ASXC, BFLY, SNWV, and RXST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2025Q2 2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$0.09$0.01+$0.10$0.01$10.14 million$10.16 million
8/7/2025Guidance Update
RxSight, Inc. stock logo
RXST
RxSight
-$0.04-$0.08-$0.04-$0.29$39.78 million$33.64 million
8/1/2025Q2 2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.07-$0.06+$0.01-$0.06$23.91 million$23.38 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
N/AN/AN/AN/AN/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
RxSight, Inc. stock logo
RXST
RxSight
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
N/A
1.00
0.69
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
5.68
4.14
RxSight, Inc. stock logo
RXST
RxSight
N/A
13.93
12.70
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/A
0.43
0.31

Institutional Ownership

CompanyInstitutional Ownership
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
9.35%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
RxSight, Inc. stock logo
RXST
RxSight
78.78%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%

Insider Ownership

CompanyInsider Ownership
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
2.87%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
25.18%
RxSight, Inc. stock logo
RXST
RxSight
9.57%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
14.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
170272.33 million264.52 millionNot Optionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
460251.74 million188.35 millionOptionable
RxSight, Inc. stock logo
RXST
RxSight
22040.92 million37.00 millionOptionable
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
408.57 million7.29 millionN/A

Recent News About These Companies

Sanuwave (SNWV) Q2 Revenue Jumps 42%
Sanuwave Announces Q2 FY2025 Financial Results
SANUWAVE Health, Inc. (SNWV): A Bull Case Theory
Sanuwave Announces Q1 FY2025 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Asensus Surgical stock logo

Asensus Surgical NYSEAMERICAN:ASXC

$0.35 0.00 (0.00%)
As of 08/22/2024

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$1.52 +0.14 (+9.71%)
Closing price 03:59 PM Eastern
Extended Trading
$1.51 -0.02 (-1.25%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

RxSight stock logo

RxSight NASDAQ:RXST

$9.28 +0.55 (+6.30%)
Closing price 04:00 PM Eastern
Extended Trading
$9.24 -0.04 (-0.43%)
As of 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$45.00 +3.74 (+9.06%)
As of 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.